SUNOL MOLECULAR
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.
Similar Organizations
AlphaSense
AlphaSense is a neurotechnology company, headquartered in Boston starting from 2013.
Anteros Pharmaceuticals
Anteros Pharmaceuticals is a biotechnology company that develops drugs for fibrotic and other inflammatory diseases.
AURA Biopharm
A new opportunity to find solutions for unmet medical needs and orphan diseases
Chromaderm
Chromaderm develops melanin production as therapy for skin brightening, melasma, and skin diseases associated with melanin production.
Imbioray
Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases.
MicroIslet
MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologes.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
ScandiBio Therapeutics
We develop metabolic co-factors that can be used in treatment of metabolic diseases.
Investors List
Techno Venture Management
Techno Venture Management investment in Venture Round - Sunol Molecular
More informations about "Sunol Molecular"
Sunol Molecular Corp. - Drug pipelines, Patents, Clinical trials
The company specializes in creating gel therapeutics for the treatment of human tissue factor-related disorders. Founded by Peter R. Rhode, Hing C. Wong, and Jon Weidanz, Sunol …See details»
Sunol Molecular Corp - Company Profile and News
Company profile page for Sunol Molecular Corp including stock price, company news, executives, board members, and contact informationSee details»
Sunol Molecular - Products, Competitors, Financials, Employees ...
About Sunol Molecular. Developer of antibody-based immunotherapeutic agents to treat disorders associated with the human tissue factor pathway. The company currently has under …See details»
Sunol Molecular Corporation - Products, Competitors, Financials ...
Sunol Molecular Corporation was founded in 1996. Where is Sunol Molecular Corporation's headquarters? Sunol Molecular Corporation's headquarters is located at 2810 North …See details»
Sunol Molecular Corporation Company Profile, Financial and
Sunol Molecular Corporation operates as a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibody-based therapeutics to treat …See details»
Sunol Molecular - Funding, Financials, Valuation & Investors
Jan 1, 2000 Experience the new Crunchbase, powered by AI . Organization. Sunol MolecularSee details»
Sunol Molecular Corporation | www.inknowvation.com
Sunol Molecular Corporation wasa biotechnology company focuses on the discovery, development, and commercialization of antibody-based therapeutics to treat disorders …See details»
Sunol Molecular Corp. /Tissue Factor Antagonist Program/
Explore Sunol Molecular Corp. /Tissue Factor Antagonist Program/ with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Sunol Molecular Corp. (Sunol Molecular Corp.) - 药物管线_专利_临 …
项与 Sunol Molecular Corp. 相关的文献（医药） 2010-01-01 · Thrombosis and haemostasis 2区 · 医学 Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor …See details»
Sunol Molecular Corp. - BioCentury Company Profiles - BCIQ
Jan 24, 2011 Sunol Molecular Corp. - BioCentury Company Profiles for the biopharma industrySee details»
Sunol Molecular: Drug pipelines, Patents, Clinical trials - Synapse
Jul 22, 2023 Explore Sunol Molecular with its drug pipeline, therapeutic area, technology platform, 3 literature, Drug:Single chain T cell receptors (Sunol Molecular). Data. Feature. …See details»
Sunol Molecular - Tech Stack, Apps, Patents & Trademarks
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.See details»
Sunol Molecular - Overview, News & Similar companies - ZoomInfo
Who is Sunol Molecular. Sunol Molecular Corp. began operations in 1996 and is a privately held company engaged in the discovery and development of novel human therapeutics to treat …See details»
SUNOL MOLECULAR CORP innovation strategy - GoodIP
SUNOL MOLECULAR CORP has a total of 85 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, Australia and WIPO (World …See details»
Sunol Moves Sunol-cH36 Into Clinic; Fund-Raising In Works
Jun 19, 2003 Since the early 1990s, some employees of Sunol Molecular Corp. have been working in the area of tissue factor, even before the company was incorporated in 1995. Now, …See details»
ALT 836 - AdisInsight - Springer
Nov 4, 2017 Originator Sunol Molecular Corporation Developer Altor BioScience Corporation Class Anti-inflammatories; Anticoagulants; Antithrombotics; Monoclonal antibodies ... If your …See details»
Anti-Shiga toxin monoclonal antibodies - Taro Pharmaceuticals
Originator Sunol Molecular Corporation; Uniformed ... New Molecular Entity Yes Available For Licensing Yes Highest Development Phases Discontinued Haemolytic ... If your organization …See details»
Single chain T cell receptors (Sunol Molecular)
项与 Single chain T cell receptors (Sunol Molecular) 相关的文献（医药） 2011-09-01 · Translational Stroke Research 2区 · 医学 Recombinant T Cell Receptor Ligands Improve …See details»
Sunol Molecular - Crunchbase
A development stage biotechnology company with products for cardiovascular, cancer and inflammatory diseases.See details»
Multimodal cell maps as a foundation for structural and functional ...
3 days ago Self-supervised multimodal data integration resolves 275 molecular assemblies spanning the range of 10−8 to 10−5 m, which we validate systematically using whole-cell size …See details»